Monterey Innovation Acquisition Corp financial data

Industry
Blank Checks
Location
17 State Street, 21 St Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
Monterey Bio Acquisition Corp (to 3/10/2023)
Latest financial report
10-Q - Q2 2023 - Aug 22, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.15 % -98.6%
Return On Equity 67.4 %
Return On Assets -2.25 % -75.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.34M shares -11.4%
Common Stock, Shares, Outstanding 2.88M shares
Entity Public Float 144M USD
Common Stock, Value, Issued 288 USD 0%

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) -2.03M USD -64.5%
Nonoperating Income (Expense) 1.2M USD +1005%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -836K USD +42.4%
Income Tax Expense (Benefit) 195K USD +1438%
Net Income (Loss) Attributable to Parent -1.03M USD +8.69%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 540K USD +10995%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD
Assets, Current 548K USD +36.6%
Assets 22.4M USD -80.8%
Liabilities, Current 2.98M USD +925%
Retained Earnings (Accumulated Deficit) -2.47M USD -119%
Stockholders' Equity Attributable to Parent -2.47M USD -764%
Liabilities and Equity 22.4M USD -80.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -133K USD +59.5%
Net Cash Provided by (Used in) Financing Activities 443K USD
Net Cash Provided by (Used in) Investing Activities -238K USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 2.88M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 72.6K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 540K USD +10995%
Deferred Tax Assets, Valuation Allowance 469K USD +328%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 469K USD +328%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 0 USD -100%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%